Fig. 1From: Tofogliflozin long-term effects on atherosclerosis progression and major clinical parameters in patients with type 2 diabetes mellitus lacking a history of cardiovascular disease: a 2-year extension study of the UTOPIA trialStudy flow chart showing patient enrollment and analysisBack to article page